Optimer Pharmaceuticals Announces Lower Recurrence Rates for Fidaxomicin Versus Vancocin(R) in Subgroup Analyses from Its Phase 3 Study for the Treatment of CDI

SAN DIEGO, June 2 /PRNewswire-FirstCall/ -- Optimer Pharmaceuticals, Inc. (Nasdaq: OPTR ) announced that additional results from its North American Phase 3 clinical study of fidaxomicin in patients with Clostridium difficile infection (CDI) were presented today by clinical investigator, Mark A...

Cimzia(R) (certolizumab pegol) Provides Long-Term Remission and Response Rates in Infliximab-Refractory Crohn's Patients

Cimzia(R) shows duration of response up to week 26 in moderate to severe Crohn's patients who failed the intravenous infusion treatment infliximab. CHICAGO, June 1 /PRNewswire/ -- New data from the WELCOME study presented by UCB at the Digestive Disease Week meeting demonstrate that Cimzia(R)...

Speid & Associates Partners With Genizon BioSciences to Reduce Attrition Rates of New Drug Compounds

SAN DIEGO and MONTREAL, Feb. 25 /PRNewswire/ -- Speid & Associates, an international regulatory and drug development consultancy firm today announced that it has entered into a partnership with Genizon BioSciences to increase success rates of new drug compounds using Genizon's proprietary gene...

TorreyPines Therapeutics Enters into Agreement to Reduce Royalty Rates and Delay Clinical Milestone Payments Due to Eli Lilly for NGX426 and Tezampanel

LA JOLLA, Calif., Nov. 25 /PRNewswire/ -- TorreyPines Therapeutics, Inc. (Nasdaq: TPTX ) today announced that it has purchased from Eli Lilly & Company a reduction in certain royalty amounts that may become payable to Eli Lilly on net sales of TorreyPines' clinical-stage compounds NGX426 and...

Germicidal UVC Lights Improve Clinical Pregnancy Rates for IVF Lab, New Study Finds

BETHLEHEM, Pa., Sept. 9 /PRNewswire/ -- A seven and a half-year study conducted in the In Vitro Fertilization Cleanroom Laboratory of the Lehigh Valley Hospital and Health Network found that the use of ultraviolet C or "UVC" lights installed in the HVAC system had a clinically significant impa...

18-Month Extension of Reimbursement Rates for Radioimmunotherapies Becomes Law After Congressional Override of Presidential Veto

SEATTLE, July 15 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) announced that Congress today passed the Medicare Improvements for Patients and Providers Act of 2008, which includes an 18-month extension of the 2007 reimbursement rate for radioimmunotherapies su...

Congress Extends 2007 Reimbursement Rates for Radioimmunotherapies for 18 Months

SEATTLE, July 9 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) announced that the Medicare Improvements for Patients and Providers Act of 2008, as passed by the U.S. House of Representatives on June 24, 2008 and the U.S. Senate on July 9, 2008, would continue th...

Avastin Used in Combination with Drugs from Bristol-Myers Squibb Has Advantages in Survival Rates Over the Current Sales-Leading Therapy for Advanced Ovarian Cancer

Avastin Used in Combination with Taxol and Paraplatin Will Become the Clinical Gold Standard Treatment by 2011, According to a New Report from Decision Resources WALTHAM, Mass., April 23 /PRNewswire/ -- Decision Resources, one of the world's leading research and ad...

Aethlon Medical Announces Data Supported Strategy to Increase Hepatitis-C (HCV) Cure Rates

SAN DIEGO, March 25 /PRNewswire-FirstCall/ -- Aethlon Medical, Inc. (OTC Bulletin Board: AEMD) today announced clinical data that supports the advancement of the Aethlon Hemopurifier(R) as an adjunct therapy to increase Hepatitis-C (HCV) cure rates. The Hemopurifier(R) is a first-in-class medical ...

Manhattan Research Ranks the Top Pharmaceutical Branded Websites by Rx Request Rates

While Chantix and Cialis Lead, Many Heavily Advertised Brands Lag Behind NEW YORK, Feb. 4 /PRNewswire/ -- Manhattan Research, a leader in syndicated research and marketing services for the health and pharmaceutical industry, today revealed the top pharmaceutical branded product websites ranked...

High taxes and low rates of entrepreneurship - is there a relationship?

Madison, Wis. - Ask a Wisconsin entrepreneur what's vital to the success of his or her business, and you're as likely to get a shopping list as a definitive answer. Finding and keeping the right employees, affording health insurance, protecting intellectual property, and cutting through governm...

Outstanding transfection rates using the Multiporator

Using eukaryotic cells, extremely high transfection rates can be achieved due to a hypoosmolar buffer system and short pulses in the s-range. High reproducibility is ensured by an electronically controlled pulse, independent of s...

Outstanding transfection rates using the Multiporator

Using eukaryotic cells, extremely high transfection rates can be achieved due to a hypoosmolar buffer system and short pulses in the s-range. High reproducibility is ensured by an electronically controlled pulse, independent of s...

KV Pharmaceutical Announces Stockholder Action to Amend By-Laws is Invalid

...ited to) the following: (1) the ability to continue as a going concern; (2) changes in the current and future business environment, including interest rates and capital and consumer spending; (3) the difficulty of predicting FDA approvals, including timing, and that any period of exclusivity may not be rea...

Microbix Sales Grow 22% For Nine Months

...he pipeline technologies; risks associated with failure to develop and commercialize SST; non-adoption of SST; risks associated with currency exchange rates which may exaggerate or reduce the actual financial performance of the Company. These forward-looking statements represent the Company's judgment as o...

OncoGenex Reports Second Quarter 2009 Financial Results

...ne -- a 6.9 month observed survival advantage for the OGX-011 arm. The unadjusted hazard ratio (HR), a measure used to compare the death rates between treatment groups, was 0.61, representing a 39% lower rate of death for patients treated with OGX-011. - Preliminary result...

Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2009

... this independent study was to evaluate restenosis rates of DES's in patients with and without diabetes in ...zotorolimus-eluting Endeavor had higher restenosis rates in patients with diabetes compared with those in p...restenosis). The corresponding event-free survival rates were 87 percent and 78 percent, and freedom from t...

The Breast Cancer Therapeutics Market in Australia

...normal cells when compared to cytotoxic chemotherapeutic drugs. New offerings must constitute therapies that will improve quality of life and survival rates if they are to thrive in this highly competitive market. "Biopharmaceutical companies are placing more emphasis on developing targeted breast ...

Shire plc: Core Portfolio of Products Delivers 20% Sales Growth

...2008. (2) Sales growth at constant exchange rates ("CER"), which is a Non GAAP measure, is calculate... 139c 95c Note: Average exchange rates for Q2 2009 were $1.55:GBP1.00 and $1.36:EUR1.00, ...tails of the effect of changes in foreign exchange rates on the earnings guidance. Specifically, our plans ...

Rib-X Pharmaceuticals Reports Positive Phase 2 Study Results for Radezolid in Community-Acquired Pneumonia

...nce daily (QD), 450 mg QD and 450 mg twice daily (BID). This novel oxazolidinone showed comparable efficacy across all three doses, with clinical cure rates in the clinically evaluable population ranging from 78% to 92%. Radezolid also showed excellent activity against a number of key CAP pathogens includi...

Techne Corporation Releases Unaudited Fourth Quarter Results for Fiscal Year 2009

...uarter ended June 30, 2009. The change in exchange rates used to convert foreign currencies (primarily Brit...year ended June 30, 2009 when measured at currency rates in effect in the comparable prior periods. R&D... $(1,816) $(3,759) Change in exchange rates to convert foreign expenses to U.S. dollars ...

International Milk Genomics & Human Health Symposium Speaker Program Announced

...er at the rate of $400 through August 23, 2009 and $450 thereafter. Student rates and special hotel room rates also are available. Additional program information is available at www.mil...

ERT Reports Second Quarter 2009 Results

...hat the amounts in our backlog will ever convert to revenue. Should the current economic conditions continue or deteriorate further, the cancellation rates that we have historically experienced could increase. Further information on potential factors that could affect the Company's financial results can ...

Endo Pharmaceuticals Reports Strong Second Quarter 2009 Financial Results

...lue of financial instruments ($0.02) ($0.02) Tax effect of pre-tax adjustments at the applicable tax rates and certain other expected cash tax savings as a result of the Indevus acquisition ($0.39) ...

Caliper Life Sciences Reports Second Quarter 2009 Results

...uarter ending September 30, 2009, Caliper's expected organic revenue growth rates for the full year, and Caliper's belief in a continuing strong demand for i...- --- ------- ------- ------- (1) For purposes of comparing growth rates for each of the three principal areas of our business, the above no...

Oncolytics Biotech(R) Inc. Announces 2009 Second Quarter Results

...e in the second quarter," said Dr. Brad Thompson, President and CEO of Oncolytics. "The results of these trials, and the response and clinical benefit rates as reported by our investigators, reinforce our belief that REOLYSIN has the potential to significantly improve treatment outcomes in patients with a ...

Elagolix Successful in Six Month Lilac Petal Study; Safety and Efficacy Confirmed in Patients With Endometriosis

...consistent with results across the entire Phase II program. Dr. O'Brien also commented, "The magnitude of improvement and the related responder rates across the numerous efficacy scales were similar for both the 150 mg and 250 mg doses of elagolix and, given the superior bone safety profile, the 150...

Sunesis Reports Financial Results for the Second Quarter 2009

... compares favorably relative to expected remission rates in this AML population of approximately 10 to 15 p.... alone. Following frontline treatment, recurrence rates among ovarian cancer patients are high. Treatment ...ly over the past 40 years, with five-year survival rates at less than 30 percent. About Sunesis Ph...

Sanofi-aventis Announces Second Quarter 2009 Results

...ed exchange 2009 basis rates H1 2009 basis rates ----...uding selected items of 17.2% at constant exchange rates and 29.9% on a reported basis ...wth in net sales is expressed at constant exchange rates unless otherwise indicated ; (2) $192.5 million i...

FluMist(R) Begins Shipping for 2009-2010 Influenza Season

...n't Play with the Flu"(TM) ( www.dontplaywiththeflu.com ), a national health awareness campaign with the goal of increasing seasonal flu vaccination rates among eligible kids and families across the country. As part of the multi-faceted campaign, FluMist has become an official sponsor of WPS, the world'...

Zimmer Launches New Medical Education and BioSkills Training Program

...endent agents and distributors who market our products; changes in general industry and market conditions, including domestic and international growth rates and general domestic and international economic conditions, including interest rate and currency exchange rate fluctuations; and the costs of defendin...

FDA Grants First Authorization of a Commercial 2009 H1N1 Flu Test for use During Pandemic Flu Emergency to Quest Diagnostics' Focus Diagnostics Business

...09 H1N1 influenza virus. By comparison, positivity rates in adults 21 to 40 years of age have averaged appr... 41 to 60 years of age have experienced positivity rates of 36 percent, while those 61 to 80 years of age have experienced positivity rates of approximately 14 percent. "Our data a...

Life Sciences Real Estate Outperforming Other Sectors

... Occupancy rates and rents for spaces leased to biotech, pharma and..., vacancies are up while absorption and net rental rates are down. But a Page 1 article in the most recent ... And in some markets, like Greater Boston, vacancy rates for lab space have actually declined.” B...

Sigma-Aldrich (Nasdaq:SIAL) Reports Q2 2009 Diluted EPS of $0.68; YTD Diluted EPS up 1.5% to $1.36. Full Year 2009 Guidance Reaffirmed, With 2009 Diluted EPS Expected to Exceed 2008's $2.65.

...ble growth in 2009 by approximately 5% if exchange rates remain at current levels. The negative impac...9 is expected to be in excess of $0.40 if exchange rates remain at current levels. Consistent with its firs...vement efforts, lower interest rates, and exchange rates remaining at current levels, we expect to report 2...

Vi typhoid vaccine proves highly effective in young children

...conducted in five Asian countries and supported by the Bill and Melinda Gates Foundation, children less than five years of age were found to have high rates of typhoid in Kolkata, India, Jakarta, Indonesia and Karachi, Pakistan, confirming that the disease is not limited to school-aged children and adults....

DNA Software, Inc. Awarded $2.5 M in NIH Funding to Develop Pioneering Nucleic Acid-based Technologies

...s via modified nucleotides, and model the reaction rates of DNA and RNA experiments. ...s via modified nucleotides, and model the reaction rates of DNA and RNA experiments. DNA Software, Inc....gens. Novel Software for Modeling PCR Reaction rates and Diagnostics with Modified Nucleotides Whil...

Axial Biotech Enters Partnership with the University of Utah to Utilize the Utah Population Database to Develop Personalized Diagnostic Tests for Spine Disorders

...nded families with multiple generations whose medical histories can be used to quickly determine heritability of complex diseases. As a result of high rates of immigration to Utah from a broad array of ethnic backgrounds, the heterogeneity allows for population studies representative of the general populat...

Neogen Reports 16% Increase in Revenues

...enues for FY 2009 were $118,721,000, up from $102,418,000 in the company's previous fiscal year. The 2009 results reflect changes in currency exchange rates that had an unfavorable impact of $2.7 million on Neogen's international net sales. Net income per share was $0.92 in FY 2009, compared to $0.81 in th...

Idenix Pharmaceuticals Reports Second Quarter and Six Month 2009 Financial Results

...ents. There can be no guarantees that historical sales of Tyzeka(R)/Sebivo(R) (telbivudine) will in any way suggest future royalty payments or royalty rates owed to the company, or that the company will advance any clinical product candidate or other component of its potential pipeline to the clinic, to th...

American Mothers Seriously Concerned About Childhood Allergies, Siemens Survey Reveals

...tests for detecting allergies common in children, including peanuts, insect venoms, milk, foods, dust and a host of other allergens,( )may have higher rates of precision, sensitivity and in some instances safety, than other diagnostic options.(4,5) Blood tests pose no risk of triggering a severe reaction i...